‘Date Rape’ Drug Gets FDA Approval to Treat Rare Sleep Disorder
FRIDAY, Aug. 13, 2021 (HealthDay News) — The drug Xywav has been approved for expanded use in adults with a rare sleep disorder called idiopathic hypersomnia, the U.S. Food and Drug Administration said Thursday. The drug has a checkered history: In the 1960s, it was given to women during childbirthContinue Reading